These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 27282362

  • 1. Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.
    Helfer B, Samara MT, Huhn M, Klupp E, Leucht C, Zhu Y, Engel RR, Leucht S.
    Am J Psychiatry; 2016 Sep 01; 173(9):876-86. PubMed ID: 27282362
    [Abstract] [Full Text] [Related]

  • 2. Antidepressant usage in schizophrenia.
    Plasky P.
    Schizophr Bull; 1991 Sep 01; 17(4):649-57. PubMed ID: 1687176
    [Abstract] [Full Text] [Related]

  • 3. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
    Correll CU, Maayan L, Kane J, Hert MD, Cohen D.
    J Clin Psychiatry; 2016 Jun 01; 77(6):e746-56. PubMed ID: 27337425
    [Abstract] [Full Text] [Related]

  • 4. Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: a systematic review of randomized trials.
    Rummel C, Kissling W, Leucht S.
    Schizophr Res; 2005 Dec 01; 80(1):85-97. PubMed ID: 16183258
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.
    Galling B, Vernon JA, Pagsberg AK, Wadhwa A, Grudnikoff E, Seidman AJ, Tsoy-Podosenin M, Poyurovsky M, Kane JM, Correll CU.
    Acta Psychiatr Scand; 2018 Mar 01; 137(3):187-205. PubMed ID: 29431197
    [Abstract] [Full Text] [Related]

  • 6. [Use of antidepressants in the treatment of negative symptoms of schizophrenia].
    Palomba A, Lodovighi MA, Belzeaux R, Adida M, Azorin JM.
    Encephale; 2015 Dec 01; 41(6 Suppl 1):6S36-40. PubMed ID: 26776391
    [Abstract] [Full Text] [Related]

  • 7. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.
    Leucht S, Leucht C, Huhn M, Chaimani A, Mavridis D, Helfer B, Samara M, Rabaioli M, Bächer S, Cipriani A, Geddes JR, Salanti G, Davis JM.
    Am J Psychiatry; 2017 Oct 01; 174(10):927-942. PubMed ID: 28541090
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.
    Tiihonen J, Wahlbeck K, Kiviniemi V.
    Schizophr Res; 2009 Apr 01; 109(1-3):10-4. PubMed ID: 19186030
    [Abstract] [Full Text] [Related]

  • 9. Antidepressants for the treatment of depression in people with schizophrenia: a systematic review.
    Whitehead C, Moss S, Cardno A, Lewis G.
    Psychol Med; 2003 May 01; 33(4):589-99. PubMed ID: 12785461
    [Abstract] [Full Text] [Related]

  • 10. [Systematic review to evaluate the efficacy, acceptability and safety of second-generation antipsychotics for the treatment of unipolar and bipolar depression.].
    Amato L, Vecchi S, Barbui C, Cruciani F, D'Amico R, Del Giovane C, Minozzi S, Mitrova Z, Saulle R, Davoli M.
    Recenti Prog Med; 2018 Oct 01; 109(10):474-486. PubMed ID: 30394408
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
    Kishi T, Matsunaga S, Iwata N.
    Eur Arch Psychiatry Clin Neurosci; 2017 Mar 01; 267(2):149-161. PubMed ID: 27318835
    [Abstract] [Full Text] [Related]

  • 12. A meta-analysis of the efficacy and safety of traditional Chinese medicine formula Ganmai Dazao decoction for depression.
    Yeung WF, Chung KF, Ng KY, Yu YM, Ziea ET, Ng BF.
    J Ethnopharmacol; 2014 Apr 28; 153(2):309-17. PubMed ID: 24632021
    [Abstract] [Full Text] [Related]

  • 13. [Antidepressive drug treatment of the schizophrenic patient].
    Petit M.
    Encephale; 1994 Dec 28; 20 Spec No 4():667-74. PubMed ID: 7895634
    [Abstract] [Full Text] [Related]

  • 14. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD007726. PubMed ID: 23543555
    [Abstract] [Full Text] [Related]

  • 15. Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics.
    Szegedi A, Verweij P, van Duijnhoven W, Mackle M, Cazorla P, Fennema H.
    J Clin Psychiatry; 2012 Dec 28; 73(12):1533-40. PubMed ID: 23290326
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence.
    Correll CU, Rubio JM, Inczedy-Farkas G, Birnbaum ML, Kane JM, Leucht S.
    JAMA Psychiatry; 2017 Jul 01; 74(7):675-684. PubMed ID: 28514486
    [Abstract] [Full Text] [Related]

  • 17. The Relevance of Negative Symptoms in Schizophrenia and How to Treat Them with Psychopharmaceuticals?
    Möller HJ.
    Psychiatr Danub; 2016 Dec 01; 28(4):435-440. PubMed ID: 27855437
    [Abstract] [Full Text] [Related]

  • 18. A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.
    Harvey RC, James AC, Shields GE.
    CNS Drugs; 2016 Jan 01; 30(1):27-39. PubMed ID: 26801655
    [Abstract] [Full Text] [Related]

  • 19. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF, Umapathy C, Musthaq M.
    Am J Psychiatry; 1999 Aug 01; 156(8):1138-48. PubMed ID: 10450252
    [Abstract] [Full Text] [Related]

  • 20. Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia.
    Terevnikov V, Joffe G, Stenberg JH.
    Int J Neuropsychopharmacol; 2015 May 19; 18(9):. PubMed ID: 25991654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.